Analysis of retinal layer thickness in diabetic macular oedema treated with ranibizumab or triamcinolone.

In DME therapy, reduction in RNFL thickness may have a considerable impact on retinal function, unrelated to the type of pharmacological treatment. Precise morphologic quantification of neurosensory layers by SD OCT offers new insight into disease pathology and therapeutic targets.